NASDAQ:CRNX

Crinetics Pharmaceuticals Stock Forecast

etoro logo Buy CRNX
*Your capital is at risk
$83.85
+0.120 (+0.143%)
At Close: Jul 27, 2026
AI Analysis AI Analysis of CRNX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add CRNX to Watchlist?
Some Reasons Why To Add CRNX:
  • +176.7% price growth over the last year
  • High gross margin of 98.9%
  • +79.4% YTD performance
PDF

Green day on Monday for Crinetics Pharmaceuticals Inc
(Updated on Jul 27, 2026)

Buy or Hold candidate since Jun 26, 2026 Gain 128.47%

The Crinetics Pharmaceuticals Inc stock price gained 0.143% on the last trading day (Monday, 27th Jul 2026), rising from $83.73 to $83.85. During the last trading day the stock fluctuated 0.394% from a day low at $83.67 to a day high of $84.00. The price has risen in 7 of the last 10 days and is up by 0.22% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 2 million more shares were traded than the day before. In total, 5 million shares were bought and sold for approximately $386.24 million.

The stock lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $89.59 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 123.42% during the next 3 months and, with a 90% probability hold a price between $116.23 and $200.16 at the end of this 3-month period.

CRNX Signals & Forecast

The Crinetics Pharmaceuticals Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $83.80 and $56.51. A breakdown below any of these levels will issue sell signals. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, July 16, 2026, and so far it has fallen -0.0715%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Crinetics Pharmaceuticals Inc stock

Crinetics Pharmaceuticals Inc finds support from accumulated volume at $83.62 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.330 between high and low, or 0.394%. For the last week, the stock has had daily average volatility of 0.240%.

Our recommended stop-loss: $80.73 (-3.72%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 7 days ago.)

Trading Expectations (CRNX) For The Upcoming Trading Day Of Tuesday 28th

For the upcoming trading day on Tuesday, 28th we expect Crinetics Pharmaceuticals Inc to open at $83.84, and during the day (based on 14 day Average True Range), to move between $82.95 and $84.75, which gives a possible trading interval of +/-$1.80 (+/-2.17%) up or down from last closing price. If Crinetics Pharmaceuticals Inc takes out the full calculated possible swing range there will be an estimated 2.17% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $83.86 (0.01%) than the support at $83.62 (0.27%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Earnings coming up

Crinetics Pharmaceuticals Inc will release earnings AMC on Tuesday, August 04, 2026.The consensus among the analysts for the expected earnings (EPS) is -$1.23. We will update the financials statements for Crinetics Pharmaceuticals Inc, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 6.21% in the first trading day after earnings release.

Is Crinetics Pharmaceuticals Inc stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Crinetics Pharmaceuticals Inc stock to perform well in the short-term.

Current score: 1.669 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 28, 2026 - $83.84 ( 0.0119%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

CRNX Performance

Trading levels for CRNX

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 84.17 0.382%
R2 84.04 0.231%
R1 83.97 0.138%
Price 83.85
S1 83.71 -0.162%
S2 83.64 -0.255%
S3 83.51 -0.405%

Accumulated Volume Support & Resistance Levels

Level Price
R3 83.90 0.0596%
R2 83.87 0.0239%
R1 83.86 0.0119%
Price 83.85
S1 83.62 -0.274%
S2 83.53 -0.382%
S3 83.49 -0.429%

FAQ

What is the symbol for Crinetics Pharmaceuticals Inc Stock and on which exchange is it traded?
The symbol for Crinetics Pharmaceuticals Inc is CRNX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Crinetics Pharmaceuticals Inc Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Crinetics Pharmaceuticals Inc stock to perform well in the short-term.

How to buy Crinetics Pharmaceuticals Inc Stock?
Crinetics Pharmaceuticals Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Crinetics Pharmaceuticals Inc Stock.

What's the current price of Crinetics Pharmaceuticals Inc Stock?
As of the end of day on the Jul 27, 2026, the price of an Crinetics Pharmaceuticals Inc (CRNX) share was $83.85.

What is the 52-week high and low for Crinetics Pharmaceuticals Inc Stock?
The 52-week high for Crinetics Pharmaceuticals Inc Stock is $84.02 and the 52-week low is $25.83.

What is the market capitalization of Crinetics Pharmaceuticals Inc Stock?
As of the Jul 27, 2026, the market capitalization of Crinetics Pharmaceuticals Inc is 8.875B.

When is the next earnings date for Crinetics Pharmaceuticals Inc?
The upcoming earnings date for Crinetics Pharmaceuticals Inc is Aug 04, 2026.
Click to get the best stock tips daily for free!
ABOUT CRINETICS PHARMACEUTICALS INC
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III clinical trial for the treatment of acromegaly, as well as completed phase II clinical trial to treat c...
GOLDEN STAR
Ticker Change Signal Date
TSCO
$30.32
4.88% Jul 23
IMMR
$6.60
17.20% Jul 23
S
SW
$43.71
14.60% Jul 23
KMT
$34.39
2.70% Jul 21
DHT
$17.31
5.66% Jul 13

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE